192 related articles for article (PubMed ID: 27165587)
1. [Efficacy of different preparations of budesonide combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome: a comparative analysis].
Ke H; Li ZK; Yu XP; Guo JZ
Zhongguo Dang Dai Er Ke Za Zhi; 2016 May; 18(5):400-4. PubMed ID: 27165587
[TBL] [Abstract][Full Text] [Related]
2. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
[TBL] [Abstract][Full Text] [Related]
4. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
5. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
Xu H; Xu P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
[TBL] [Abstract][Full Text] [Related]
7. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
[TBL] [Abstract][Full Text] [Related]
8. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of inhalation of pulmonary surfactant using vibrating mesh nebulizers combined with nasal continuous positive airway pressure in the treatment of neonatal respiratory distress syndrome].
Gao Y; Chen X; Zhang Z; Qu S; Sang X; Wu Y; Zhou R; Peng W; Chen Y; Wang Y; Zhuo F; Chen L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jan; 34(1):80-84. PubMed ID: 35307066
[TBL] [Abstract][Full Text] [Related]
10. Effect of pulmonary surfactant combined with mechanical ventilation on oxygenation functions and expressions of serum transforming growth factor-beta1 (TGF-β1) and bone morphogenetic protein 7 (BMP-7) of neonatal respiratory distress syndrome.
Wang LP; Mao QH; Yang L
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(19):4357-4361. PubMed ID: 29077160
[TBL] [Abstract][Full Text] [Related]
11. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
Dolma K; Zayek M; Gurung A; Eyal F
Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
[TBL] [Abstract][Full Text] [Related]
12. The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical trial.
Marzban A; Mokhtari S; Tavakkolian P; Mansouri R; Jafari N; Maleki A
BMC Pediatr; 2024 Apr; 24(1):262. PubMed ID: 38643076
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
Heo M; Jeon GW
Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
[TBL] [Abstract][Full Text] [Related]
14. Surfactant and budesonide for respiratory distress syndrome: an observational study.
Kothe TB; Sadiq FH; Burleyson N; Williams HL; Anderson C; Hillman NH
Pediatr Res; 2020 Apr; 87(5):940-945. PubMed ID: 31715622
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
[No Abstract] [Full Text] [Related]
16. [Clinical efficacy of porcine pulmonary surfactant combined with budesonide suspension intratracheal instillation in the treatment of neonatal meconium aspiration syndrome].
Tan XZ; Wu SG; Zhang JH; Li XF; Gao PM; Wang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1237-1241. PubMed ID: 27974114
[TBL] [Abstract][Full Text] [Related]
17. Budesonide and Poractant Alfa prevent bronchopulmonary dysplasia via triggering SIRT1 signaling pathway.
Du FL; Dong WB; Zhang C; Li QP; Kang L; Lei XP; Guo L; Zhai XS
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):11032-11042. PubMed ID: 31858575
[TBL] [Abstract][Full Text] [Related]
18. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
[TBL] [Abstract][Full Text] [Related]
19. Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants.
Moschino L; Nardo D; Bonadies L; Stocchero M; Res G; Priante E; Salvadori S; Baraldi E
Pediatr Pulmonol; 2021 Jul; 56(7):2114-2124. PubMed ID: 33942570
[TBL] [Abstract][Full Text] [Related]
20. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
